FdaApplication
ANDA 202396
Identifiers
- fda_app_no: ANDA202396
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2018-11-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LANSOPRAZOLE | LANSOPRAZOLE | 30MG | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL |
| LANSOPRAZOLE | LANSOPRAZOLE | 15MG | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL |
2 products